Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Pearson

Showing results (411-420 of 578) with videos related to

Pageof 58
Sort By:
Cancer Research|August 17, 2012
LRP1B deletion in high-grade serous ovarian cancers is associated with acquired chemotherapy resistance to liposomal doxorubicinPrue A Cowin, Joshy George, Sian Fereday, et al.
Plos One|May 3, 2011
Deregulation of MYCN, LIN28B and LET7 in a molecular subtype of aggressive high-grade serous ovarian cancersÅslaug Helland, Michael S Anglesio, Joshy George, et al.
Nature Communications|March 2, 2022
Adaptive translational reprogramming of metabolism limits the response to targeted therapy in BRAF<sup>V600</sup> melanomaLorey K Smith, Tiffany Parmenter, Margarete Kleinschmidt, et al.
Science Signaling|October 2, 2014
Partial inhibition of gp130-Jak-Stat3 signaling prevents Wnt-β-catenin-mediated intestinal tumor growth and regenerationToby J Phesse, Michael Buchert, Emma Stuart, et al.
Wellcome Open Research|May 24, 2024
Improving modelling for epidemic responses: reflections from members of the UK infectious disease modelling community on their experiences during the COVID-19 pandemicKatharine Sherratt, Anna C Carnegie, Adam Kucharski, et al.
Molecular Cancer Therapeutics|April 9, 2015
Enhanced GAB2 Expression Is Associated with Improved Survival in High-Grade Serous Ovarian Cancer and Sensitivity to PI3K InhibitionSally J Davis, Karen E Sheppard, Michael S Anglesio, et al.
Science (New York, N.Y.)|March 4, 2021
Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in EnglandNicholas G Davies, Sam Abbott, Rosanna C Barnard, et al.
Plos Genetics|February 15, 2013
Autophagy induction is a Tor- and Tp53-independent cell survival response in a zebrafish model of disrupted ribosome biogenesisYeliz Boglev, Andrew P Badrock, Andrew J Trotter, et al.
Nature Communications|May 28, 2020
CX-5461 activates the DNA damage response and demonstrates therapeutic efficacy in high-grade serous ovarian cancerElaine Sanij, Katherine M Hannan, Jiachen Xuan, et al.
Nature Communications|June 19, 2026
Recurrent intra-tumour heterogeneity is a hallmark of metastatic prostate cancerSirui Weng, Lachlan Cain, James Comben, et al.
Pageof 58

Showing results (411-420 of 578) with videos related to

Sort By:
Pageof 58
Cancer Research|August 17, 2012
LRP1B deletion in high-grade serous ovarian cancers is associated with acquired chemotherapy resistance to liposomal doxorubicinPrue A Cowin, Joshy George, Sian Fereday, et al.
Plos One|May 3, 2011
Deregulation of MYCN, LIN28B and LET7 in a molecular subtype of aggressive high-grade serous ovarian cancersÅslaug Helland, Michael S Anglesio, Joshy George, et al.
Nature Communications|March 2, 2022
Adaptive translational reprogramming of metabolism limits the response to targeted therapy in BRAF<sup>V600</sup> melanomaLorey K Smith, Tiffany Parmenter, Margarete Kleinschmidt, et al.
Science Signaling|October 2, 2014
Partial inhibition of gp130-Jak-Stat3 signaling prevents Wnt-β-catenin-mediated intestinal tumor growth and regenerationToby J Phesse, Michael Buchert, Emma Stuart, et al.
Wellcome Open Research|May 24, 2024
Improving modelling for epidemic responses: reflections from members of the UK infectious disease modelling community on their experiences during the COVID-19 pandemicKatharine Sherratt, Anna C Carnegie, Adam Kucharski, et al.
Molecular Cancer Therapeutics|April 9, 2015
Enhanced GAB2 Expression Is Associated with Improved Survival in High-Grade Serous Ovarian Cancer and Sensitivity to PI3K InhibitionSally J Davis, Karen E Sheppard, Michael S Anglesio, et al.
Science (New York, N.Y.)|March 4, 2021
Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in EnglandNicholas G Davies, Sam Abbott, Rosanna C Barnard, et al.
Plos Genetics|February 15, 2013
Autophagy induction is a Tor- and Tp53-independent cell survival response in a zebrafish model of disrupted ribosome biogenesisYeliz Boglev, Andrew P Badrock, Andrew J Trotter, et al.
Nature Communications|May 28, 2020
CX-5461 activates the DNA damage response and demonstrates therapeutic efficacy in high-grade serous ovarian cancerElaine Sanij, Katherine M Hannan, Jiachen Xuan, et al.
Nature Communications|June 19, 2026
Recurrent intra-tumour heterogeneity is a hallmark of metastatic prostate cancerSirui Weng, Lachlan Cain, James Comben, et al.
Pageof 58